reference/10622966

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10622966

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1753
issn	0022-1007 1540-9538
issueIdentifier	8
pageRange	1739-1753
publicationName	The Journal of experimental medicine
startingPage	1739
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_518c21bda757d4d22577418483cbac46 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_05f7fb873857cba38536f004758262d8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3c90935689a11a0c23e14fff43a1d2b2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d7f4594e3253c0aa7ceef51bde4f35a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a80969b030770a88f6449c9958335e4f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f59c683fe4206686ee8083790c06aeb2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5f16062bf39c1ad2ebda4cbadd401864 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5ff8f57bd5b0000444a36134f383c56b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2620406b75661a18ba93fc7dd0e50f50 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c9c71daa6dc96074bec1df2ee8f4284c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_86293694af0d13e851187dca175b3148 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1f65e44bd5b00e2b137265605412c1e1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b3fb61475858f774e4dd3fdd4fbbeb56 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_87e21bbffd02daad81694d447cb5736d
bibliographicCitation	Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L, Park E, Schuh W, Gruber T, Herzog S, Kim YM, Hofmann WK, Li A, Storlazzi CT, Jäck HM, Groffen J, Martinelli G, Heisterkamp N, Jumaa H, Müschen M. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med. 2009 Aug 03;206(8):1739–53. PMID: 19620627; PMCID: PMC2722172.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3aa48f24598651c1bb8339d5b133edb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37b6b5d29b13b08d4ae6a9756a35ea2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8cdb97e62ae0f16995c6784026efd22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77ab15f1a0eed261b0b6b494c2726937 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f065a8a8dc3efc5326b0fa30382f257c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a955a52c9b0d376d55464b6204083d7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7d5744389669ff1cea1f2fe33dd99ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_540c65810e4397d0d614d971b03eb29f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32c734f3967711860716c8cf51c9c451 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d6470768c40eaaa7ac7db26836bc916 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11b051a5a9c54e72306764d827bca6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb221acd949497822ac6c402156d955d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_916dcca21e13f6e81e64c0dfc6e0aa80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f22cf851d450cff4f577ff88137079de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7dc8a6eee80bf1f2aa90796cff3022e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ce7fe2c248f0ef8276045674a131937 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30ebe25e03d1fbaf8bef4bbc544a6b3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fd83e606bdc42fff1b3eee82f0a5362 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6248348b0861dd058c09272c972bc24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e2fc9f2719e4112be0f7bfb89efce87
date	2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2722172 https://pubmed.ncbi.nlm.nih.gov/19620627 https://doi.org/10.1084/jem.20090004
isPartOf	https://portal.issn.org/resource/ISSN/0022-1007 https://portal.issn.org/resource/ISSN/1540-9538 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4724
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function
discusses	http://id.nlm.nih.gov/mesh/M0450844 http://id.nlm.nih.gov/mesh/M0360194 http://id.nlm.nih.gov/mesh/M0294043 http://id.nlm.nih.gov/mesh/M0208676 http://id.nlm.nih.gov/mesh/M0462870
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054420Q000502 http://id.nlm.nih.gov/mesh/D010677 http://id.nlm.nih.gov/mesh/D054403Q000235 http://id.nlm.nih.gov/mesh/D051740Q000502
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D054403Q000473 http://id.nlm.nih.gov/mesh/D018345 http://id.nlm.nih.gov/mesh/D054420Q000172 http://id.nlm.nih.gov/mesh/D054420Q000235 http://id.nlm.nih.gov/mesh/D002453 http://id.nlm.nih.gov/mesh/D016313 http://id.nlm.nih.gov/mesh/D017353 http://id.nlm.nih.gov/mesh/D002471Q000276 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D051740Q000235 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D054403Q000503 http://id.nlm.nih.gov/mesh/D015536 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002471Q000235 http://id.nlm.nih.gov/mesh/D048868Q000502 http://id.nlm.nih.gov/mesh/D051740Q000172 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2e4906e8c6048d6263e53edaeb34ea09 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472a53b1a4ec3818b8392773f5523355 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1d22db93c514ed7e365d1707db3ad94 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17060 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10320 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19374

Total number of triples: 95.